imaGenes Appointed as BioTrove OpenArray® Service Provider
First service provider outside the U.S. will pave the way for European marketBerlin and Woburn - The Berlin-based integrated genomics services specialist imaGenes will complement its offerings with BioTrove's OpenArray(R) Platform, a nanoliter Real-Time qPCR, allowing for about 9,000 assays simultaneously.
The high throughput OpenArray(R) platform delivers superior performance to comparative qPCR systems in a much easier to use format. OpenArray(R) produces more results faster, allowing gene expression profiling, microRNA profiling analyses and biomarker studies to be completed in days instead of weeks and at a much lower price. OpenArray(R) technology utilizes nanoliter fluidics enabling one person to generate over 27,000 assays per day.
OpenArray(R) offers six logs of sensi¬tivity in a miniaturized customizable parallel array format with excellent corre¬lation to data from conventional large volume Real-Time PCR. There¬fore, this platform fills a huge gap for experiments where microarray data lack accuracy and next generation sequencing is not cost-efficient.
imaGenes is BioTrove's first OpenArray(R) Service Provider for Real-Time qPCR Analysis outside the U.S. "We chose imaGenes for their extensive experience in microarray and next generation sequencing services. A spirited company with a well established quality management is an ideal partner to convince customers of the benefits of BioTrove's OpenArray(R) platform" says Derek Potter, BioTrove's European Director.
OpenArray(R) supports both TaqMan(R) and SYBR(R) chemistries. As an alternative to customer-designed assays, ready-to-use OpenArray(R) Pathways gene panels are also offered and contain bench-validated real-time qPCR assays. They provide to researchers a comprehensive set of gene families to aid the study of cancer, cardiovascular disease, inflammatory disease and basic cellular systems. Each plate in the OpenArray(R) Pathways product family contains 600+ laboratory tested assays.
About imaGenes :
imaGenes GmbH, Berlin, is a premier provider of genome research services in Europe and was founded in 2007 as a spin-off from RZPD (German Resource Center for Genome Research). imaGenes manages one of the most comprehensive collections of clones of mammalian and vertebrate genes in the world offered via its clone search engine GenomeCube(R), linked to international databases. The imaGenes research services feature a broad range of microarray applications on Affymetrix, Agilent, and NimbleGen platforms, OpenArray RT-qPCR from BioTrove as well as next generation sequencing services on an Illumina Genome Analyzer System. Researchers in academia and in the pharmaceutical industry are provided with highest quality resources and innovative technology with maximum flexibility and cost effectiveness. imaGenes is fully compliant with ISO 9001:2008 quality standards. A comprehensive overview can be found at www.imagenes-bio.de or www.rzpd.de.
BioTrove, Inc. offers two innovative technology platforms: OpenArray(R), which advances genomic research in a wide range of life science fields, including agriculture, disease research, and public health, and RapidFire(R), which enables the acceleration of drug discovery and pipeline decisions. With 11 of the 12 largest biopharmaceutical companies based on global sales as clients, and partnerships with prestigious research and public health centers around the world, BioTrove's products and services ensure that an industry committed to accuracy and speed can meet business goals.
The OpenArray(R) Platform
The OpenArray(R) Platform enables genomics researchers to generate SNP and real time qPCR data in the hundreds of thousands of data points per day, significantly increasing the number of samples analyzed while significantly decreasing the time and cost required. The flexible format and nanoliter scale of the OpenArray system allows for easy adjustment of sample and assay numbers, achieving economical, high-throughput genomics. Life Technologies globally markets the OpenArray SNP genotyping platform under the TaqMan(R) OpenArray(R) SNP Genotyping brand. BioTrove is a licensee of Life Technologies global patent rights related to the real-time thermal cyclers, microfluidics and data analysis.
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.